Skip to main content
Top
Published in: Supportive Care in Cancer 2/2010

01-02-2010 | Original Article

GP-led melanoma follow-up: views and feelings of patient recipients

Authors: Peter Murchie, Elizabeth K. Delaney, Neil C. Campbell, Philip C. Hannaford

Published in: Supportive Care in Cancer | Issue 2/2010

Login to get access

Abstract

Objectives

The aim of this study was to explore the practical experiences and feelings of people with cutaneous malignant melanoma about receiving structured melanoma follow-up from their general practitioner (GP) as an alternative to traditional hospital-based follow-up.

Design

Semi-structured audio-taped telephone interviews were conducted with patient recipients of a GP-led follow-up programme for people with cutaneous malignant melanoma.

Subjects

Eighteen people with cutaneous malignant melanoma that had received structured GP-led routine follow-up for cutaneous malignant melanoma took part in this study.

Results

GP-led melanoma follow-up worked well from the perspectives patients. Patients appreciated convenience of the system, less rushed appointments with more thorough examinations, a more pleasant atmosphere and greater continuity of care. They regarded the GP-led follow-up positively, irrespective of distance from the major cancer centre. Concerns expressed included awareness that most GPs had less experience of melanoma than hospital specialists.

Conclusions

GP-led melanoma follow-up is feasible and is generally viewed positively by those patients that have experienced it.
Literature
1.
go back to reference Maher J, Bradburn J, Adewuyi-Dalton R (1995) Patients prefer specialist follow-up. BMJ 311:54PubMed Maher J, Bradburn J, Adewuyi-Dalton R (1995) Patients prefer specialist follow-up. BMJ 311:54PubMed
8.
go back to reference Mason J (2002) Qualitative researching. Sage, London Mason J (2002) Qualitative researching. Sage, London
10.
go back to reference Murchie P, Hannaford PC, Wyke S, Nicolson MC, Campbell NC (2007) Designing an integrated follow-up programme for people treated for cutaneous malignant melanoma: a practical application of the MRC framework for the design and evaluation of complex interventions to improve health. Fam Pract 24:283–292. doi:10.1093/fampra/cmm006 CrossRefPubMed Murchie P, Hannaford PC, Wyke S, Nicolson MC, Campbell NC (2007) Designing an integrated follow-up programme for people treated for cutaneous malignant melanoma: a practical application of the MRC framework for the design and evaluation of complex interventions to improve health. Fam Pract 24:283–292. doi:10.​1093/​fampra/​cmm006 CrossRefPubMed
11.
go back to reference Kuzel AJ (1992) Sampling in qualitative inquiry. In: Crabtree BF, Miller WL (eds) Doing qualitative research. Sage, London, p 33 Kuzel AJ (1992) Sampling in qualitative inquiry. In: Crabtree BF, Miller WL (eds) Doing qualitative research. Sage, London, p 33
12.
go back to reference Taylor SJ, Bogdan R (1984) Introduction to qualitative research methods: the search for meanings. Wiley, New York Taylor SJ, Bogdan R (1984) Introduction to qualitative research methods: the search for meanings. Wiley, New York
13.
go back to reference Meadows LM, Morse JM, Kuzel AJ (2002) The nature of qualitative evidence. Sage, London Meadows LM, Morse JM, Kuzel AJ (2002) The nature of qualitative evidence. Sage, London
14.
go back to reference Murchie P, Campbell NC, Ritchie LD, Thain J (2005) Running nurse-led secondary prevention clinics for coronary heart disease in primary care: qualitative study of health professionals’ perspectives. Br J Gen Pract 55:522–528PubMed Murchie P, Campbell NC, Ritchie LD, Thain J (2005) Running nurse-led secondary prevention clinics for coronary heart disease in primary care: qualitative study of health professionals’ perspectives. Br J Gen Pract 55:522–528PubMed
Metadata
Title
GP-led melanoma follow-up: views and feelings of patient recipients
Authors
Peter Murchie
Elizabeth K. Delaney
Neil C. Campbell
Philip C. Hannaford
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 2/2010
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0648-9

Other articles of this Issue 2/2010

Supportive Care in Cancer 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine